In 2026, the Neurodiagnostics Market is expanding beyond "Sick Care" and into "Proactive Wellness." The 2026 market for "Genetic Neurological Screening" is expected to reach a record share of 43.5% within the diagnostic segment. This year, consumers are increasingly utilizing advanced genomic panels to identify predispositions for conditions like late-onset Alzheimer’s or...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)